Replies to post #4023 on Dendreon Corp fka DNDNQ

[io_io]

<<<<"debating about it as an investment vehicle........but Dendreon has been quite good for me">>>>>


Ocyan - good to hear, and many owe you thanks for making the case that Provenge had a clear case and therefore DNDN had a very favorable risk/reward ratio. And personal thanks for your time in the past to assist in statistical points.

There is little point continuing your thread with Dew - remember he is a Poster first and an Investor last - or not at all, in the case of DNDN.

So to change the subject, as you looking around at other stocks, other data ? For example, I was looking at ALTH recently, that brain-mets drug might do it, and certainly survival is on the long side. Also waiting to see what data UTHR puts up for Ovarexx (ASCO today I think).

[DewDiligence]

>When you have made up your mind with questionable ground facts, your inference is suspected.<

The “ground facts” come directly from slide #19 of DNDN’s Bank of America webcast, which is shown in the next post.